Skip to main content

Distinguished Speaker Series | François. F. Paquet-Durand, PhD

-
Location
https://ucihealth.zoom.us/j/92801383742?pwd=vfI4WBKGwibdfbtyznYWvAbSg3CccO.1
Event Type

Add to Calendar: Outlook | Google | iCal

The Center for Translational Vision Research Distinguished Speaker Series, also known as "Friday Seminars" showcases innovative research across the world. The seminar series has now been expanded to include lectures by experts on topics ranging from Ophthalmology, Genetics, Biochemistry, Neurobiology, Imaging, Computational Sciences to Novel Ophthalmic Treatments.

All talks are hybrid. You can join us in person at

The Falling Leaves Foundation Building, Main Entrance Level

Conference Room (2nd Floor by signage)

847 Health Sciences Quad

You can also join us by zoom. Zoom link and information are on your right and in the calendar links above.

February 6, 2026 | François. F. Paquet-Durand, PhD

Developing PKG inhibitors for the mutation-independent treatment of retinitis pigmentosa

 

Learn More About the Distinguished Speaker Series

Featured


François. F. Paquet-Durand, PhD
François. F. Paquet-Durand, PhD
  • François. F. Paquet-Durand, PhD, Professor, Cell Death Mechanism Group, Institute for Ophthalmic Research, University of Tübingen

François F. Paquet-Durand, PhD, is a Professor of Retinal Neurodegeneration at the UCL Institute of Ophthalmology and a member of the UCL Centre for Translational Vision Research. Trained as a molecular biologist and neuroscientist, his work focuses on understanding the cellular and molecular mechanisms underlying inherited retinal degenerative diseases. Dr. Paquet-Durand’s research has been instrumental in uncovering pathways of photoreceptor cell death and survival, particularly in conditions such as retinitis pigmentosa. His laboratory investigates how dysregulated signaling, metabolic stress, and neuroinflammation contribute to retinal degeneration, with the goal of identifying therapeutic strategies that slow or prevent vision loss. Using advanced molecular, genetic, and pharmacological approaches, his work aims to translate fundamental insights into neurodegeneration into effective treatments that preserve retinal function and visual capacity.